FDA Revokes Emergency Use of Hydroxychloroquine to Fight Coronavirus
WASHINGTON – The Food and Drug Administration revoked its emergency authorization of hydroxychloroquine and chloroquine for treating COVID-19 as evidence mounts that the drugs don’t work and can cause serious side effects.
“We’ve made clear throughout the public health emergency that our actions will be guided by science and that our decisions may evolve as we learn more about the SARS-CoV-2 virus, review the latest data, and consider the balance of risks versus benefits of treatments for COVID-19,” said Dr. Anand Shah, FDA deputy commissioner for Medical and Scientific Affairs.
Dr. Patrizia Cavazzoni, acting director of the FDA’s Center for Drug Evaluation, said while additional clinical trials will continue to evaluate the potential benefit of these drugs in treating or preventing COVID-19, “we determined the emergency use authorization was no longer appropriate.”
Cavazzoni explained the decision to revoke the drugs emergency approval was taken following “a rigorous assessment” by scientists at the Center for Drug Evaluation and Research.
“We remain committed to using every tool at our disposal in collaboration with innovators and researchers to provide sick patients timely access to appropriate new therapies,” Cavazzoni said. “Our decisions will always be based on objective and rigorous evaluation of the scientific data. This will never change.”
President Donald Trump had aggressively pushed the drug beginning in the first weeks of the outbreak and stunned medical professionals when he revealed he took the drug preemptively against infection.
All this despite the fact no large studies have found the drugs safe or effective for preventing or treating COVID-19.
Last week, a National Institutes of Health panel of experts revised its recommendations to specifically recommend against the drug’s use except in formal studies
The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage.
The FDA’s formal statement on the matter said, “in light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorized use.”
The agency’s decision means that shipments of the drugs obtained by the federal government will no longer be distributed to state and local health authorities for use against the coronavirus.
In The News
WASHINGTON — Dr. Anthony Fauci says if a coronavirus vaccine is available, regardless of which one, take it. The top U.S. infectious disease expert told NBC on Thursday a third vaccine becoming available “is nothing but good news” and would help control of the pandemic. U.S.... Read More
WASHINGTON — President Joe Biden said during a virtual meeting with essential workers on Wednesday that the administration plans to distribute millions of cloth face masks beginning early next month. According to a statement from the White House, the reusable, American-made masks will be available beginning in March... Read More
WASHINGTON (AP) — Johnson & Johnson's single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic. The Food and Drug Administration's scientists confirmed that overall the... Read More
WASHINGTON — The House Budget Committee approved reconciliations to President Joe Biden’s proposed $1.9 trillion novel coronavirus relief legislation Monday, setting in motion the bill’s final vote in the full House of Representatives expected to follow this week. If enacted, the legislation would provide $1,400 economic... Read More
WASHINGTON (AP) — Democratic leaders have a potent dynamic on their side as Congress preps for its first votes on the party's $1.9 trillion COVID-19 relief bill: Would any Democrat dare cast the vote that scuttles new President Joe Biden's leadoff initiative?Democrats' wafer-thin 10-vote House majority... Read More
The U.S. stood Sunday at the brink of a once-unthinkable tally: 500,000 people lost to the coronavirus.A year into the pandemic, the running total of lives lost was about 498,000 — roughly the population of Kansas City, Missouri, and just shy of the size of Atlanta.... Read More